⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

CRL

Charles River Laboratories International, Inc.

Healthcare · Diagnostics & Research

278.35USD

-2.4100 (-0.86%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Computing valuation metrics…

Valuation

P/E (TTM)

—

P/E (Forward)

21.94x

EV/EBITDA

41.99x

EV/Revenue

4.07x

P/S (TTM)

3.35x

P/B

4.72x

FCF Yield

2.76%

Dividend Yield

0.00%

Gross Margin

35.24%

Operating Margin

2.25%

Net Margin

-5.96%

Peer Comparison — Diagnostics & Research

CompanyMkt CapP/EEV/EBITDAFCF YieldRev GrowthDiv Yield
CRLCharles River Laboratories International, Inc.$13.41B—41.99x2.76%-2.72%0.00%
TMOThermo Fisher Scientific Inc.$223.95B32.62x22.37x2.79%10.50%0.31%

Subject metrics from SEC filings where available; peer metrics from cached market data.

DHRDanaher Corporation
$144.01B
36.58x
20.90x
3.00%
5.50%
0.78%
IQVIQVIA Holdings Inc.$42.30B31.96x18.69x5.08%8.70%—
AAgilent Technologies, Inc.$40.81B28.55x21.05x2.60%8.10%0.69%
IDXXIDEXX Laboratories, Inc.$40.58B36.15x25.58x2.24%9.70%—
WATWaters Corporation$39.75B102.48x30.66x-0.36%113.40%—
ILMNIllumina, Inc.$30.95B38.25x27.98x2.58%9.40%—
LHLabcorp Holdings Inc.$26.04B26.58x14.11x3.43%5.80%0.89%